UK markets open in 6 hours 43 minutes

Arcus Biosciences, Inc. (RCUS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
16.78-0.12 (-0.71%)
At close: 04:00PM EDT
16.75 -0.03 (-0.18%)
After hours: 07:38PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-231,000
-307,000
-267,000
53,000
-123,000
Depreciation & amortisation
9,000
8,000
6,000
4,000
3,000
Stock-based compensation
74,000
73,000
65,000
55,000
22,000
Change in working capital
-70,000
-71,000
623,000
-376,000
208,000
Accounts receivable
-
-
-
-17,046
-917
Accounts payable
-12,000
-1,000
8,000
-5,000
9,000
Other working capital
-235,000
-330,000
426,000
-282,000
108,000
Other non-cash items
9,000
10,000
11,000
3,000
1,000
Net cash provided by operating activities
-210,000
-306,000
438,000
-256,000
111,000
Cash flows from investing activities
Investments in property, plant and equipment
-25,000
-24,000
-12,000
-26,000
-3,000
Purchases of investments
-1,021,000
-788,000
-1,241,000
-719,000
-740,000
Sales/maturities of investments
942,000
1,006,000
837,000
741,000
309,000
Net cash used for investing activities
-104,000
194,000
-413,000
-4,000
-434,000
Cash flows from financing activities
Common stock issued
253,000
25,000
0
220,000
434,000
Common stock repurchased
-
-
-
-6
-54
Other financing activities
-
-
10,000
5,000
-
Net cash used provided by (used for) financing activities
261,000
33,000
33,000
237,000
439,000
Net change in cash
-53,000
-79,000
58,000
-23,000
116,000
Cash at beginning of period
241,000
209,000
151,000
174,000
58,000
Cash at end of period
188,000
130,000
209,000
151,000
174,000
Free cash flow
Operating cash flow
-210,000
-306,000
438,000
-256,000
111,000
Capital expenditure
-25,000
-24,000
-12,000
-26,000
-3,000
Free cash flow
-235,000
-330,000
426,000
-282,000
108,000